| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/20/2011 | CN101199663B Chinese medicine for treating psoriasis and preparing method thereof |
| 07/20/2011 | CN101185722B Infusion medicine for treating beriberi |
| 07/20/2011 | CN101172129B Traditional Chinese medicine composition for treating hypodermal ecchymosis and method of preparing the same |
| 07/20/2011 | CN101167841B Medicine for curing venereal disease and inflammation |
| 07/20/2011 | CN101164590B Traditional Chinese medicine orally administered cream for leveling scar, eliminating striae gravidarum and wrinkle, and preparation method |
| 07/20/2011 | CN101085043B Method for preparing forsythia suspense extraction |
| 07/20/2011 | CN101019576B Beatifying milk tablet |
| 07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981899 Skin aging resistance, wrinkling resistance; (S)-1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid |
| 07/19/2011 | US7981895 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group |
| 07/19/2011 | US7981426 Method for stimulating wound healing |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2485677C Methods of treating allergic reactions |
| 07/19/2011 | CA2485503C Phenyl-thiophene type vitamin d receptor modulators |
| 07/19/2011 | CA2477232C Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2467046C Process for the manufacture of human mononuclear phagocytic leukocytes |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011085356A2 Povidone-iodine and sucrose wound healing dressing |
| 07/14/2011 | WO2011085278A2 Topical scar treatment composition |
| 07/14/2011 | WO2011085013A2 Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same |
| 07/14/2011 | WO2011083853A1 Anti-atopic dermatitis agent |
| 07/14/2011 | WO2011083738A1 Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application |
| 07/14/2011 | WO2011083154A1 Dry powder fibrin sealant |
| 07/14/2011 | WO2011082732A1 Sphingosine kinase inhibitors |
| 07/14/2011 | WO2011045682A3 Active agent containing polymer network delivery composition and articles using the same |
| 07/14/2011 | WO2011045681A3 Carbohydrate entrapped active agent delivery composition and articles using the same |
| 07/14/2011 | WO2011035158A3 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| 07/14/2011 | WO2011034323A3 Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
| 07/14/2011 | WO2011026094A3 Stable aerosol topical foams comprising a hypochlorite salt |
| 07/14/2011 | WO2011026076A3 Topical formulations comprising a steroid |
| 07/14/2011 | WO2011014883A3 Skin rejuvenation and wrinkle treatment by gingival fibroblast and its growth factor: activation of effect by hyluronic acid |
| 07/14/2011 | US20110172704 Solder formulation and use in tissue welding |
| 07/14/2011 | US20110172591 Portable topical hyperbaric skin therapy and wound treatment system |
| 07/14/2011 | US20110172580 Wound care dressing |
| 07/14/2011 | US20110172310 Di-fluoro containing compounds as cysteine protease inhibitors |
| 07/14/2011 | US20110172299 Therapeutic substituted cyclopentanes |
| 07/14/2011 | US20110172296 Modulation of transforming growth factor-beta 1 expression |
| 07/14/2011 | US20110172285 Proteasome inhibitors |
| 07/14/2011 | US20110172282 Use of spiro-oxindole compounds as therapeutic agents |
| 07/14/2011 | US20110172278 Compounds and methods for modulating g protein-coupled receptors |
| 07/14/2011 | US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/14/2011 | US20110172265 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/14/2011 | US20110172250 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172235 Substituted triazolophthalazine derivatives |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172209 3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders |
| 07/14/2011 | US20110172189 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use |
| 07/14/2011 | US20110172176 Crystal structures of sglt2 inhibitors and processes for preparing same |
| 07/14/2011 | US20110172161 Composition for therapeutic and cosmetic botulinum toxin |
| 07/14/2011 | US20110172160 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 07/14/2011 | US20110172155 Beta thymosin fragments |
| 07/14/2011 | US20110172153 Screening methods using g-protein coupled receptors and related compositions |
| 07/14/2011 | US20110172150 Tissue regeneration method |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171326 Pharmaceutical material for psoriasis treatment |
| 07/14/2011 | US20110171311 Stable hydrogel compositions including additives |
| 07/14/2011 | US20110171310 Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| 07/14/2011 | US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains |
| 07/14/2011 | US20110171284 Povidone-iodine and sucrose wound healing dressing |
| 07/14/2011 | US20110171277 Wound dressing having a polyurethane foam layer and a cover layer made of thermoplastic polymer |
| 07/14/2011 | US20110171270 Novel solid state forms of laquinimod and its sodium salt |
| 07/14/2011 | US20110171265 Composition Comprising Parasite Eggs and Methods for Isolation and Storage of Parasite Eggs |
| 07/14/2011 | US20110171239 pH INDUCED SILK GELS AND USES THEREOF |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171227 Methods and compositions for treatment of skin disorders |
| 07/14/2011 | US20110171207 Compositions and methods for treating inflammation and auto-immune diseases |
| 07/14/2011 | US20110171201 Formulation for Oral Administration of Proteins |
| 07/14/2011 | US20110171188 Non-thermal plasma for wound treatment and associated apparatus and method |
| 07/14/2011 | US20110171186 Chondrocyte therapeutic delivery system |
| 07/14/2011 | US20110171180 Bioengineered skin substitutes |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171156 Topical Scar Treatment Composition |
| 07/14/2011 | CA2785595A1 Dry powder fibrin sealant |
| 07/14/2011 | CA2784647A1 Inhibitors of sphingosine kinase |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343299A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343298A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 07/13/2011 | EP2343273A1 Novel type i natural ceramide derivative and method for producing same |
| 07/13/2011 | EP2343079A2 Cell suspension preparation device |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2343061A1 Use of tall oil pitch extract and compositions which contain it |
| 07/13/2011 | EP2343044A1 Cosmetic composition for sensitive skins |
| 07/13/2011 | EP2342203A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/13/2011 | EP2341934A2 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 07/13/2011 | EP2341917A2 A topical composition comprising extracts of a. indica and m. charantia or s. indicum |
| 07/13/2011 | EP2341916A1 Colostrum composition |
| 07/13/2011 | EP2341915A1 Phosphorylated dendrimers as antiinflammatory drugs |
| 07/13/2011 | EP2341913A1 Method of enhancing tgf-beta signalling |
| 07/13/2011 | EP2341891A2 Monoester of n-undecylenoyl phenylalanine and polyol, method for preparing same, and use of said esters as a skin lightening agent |
| 07/13/2011 | EP2341888A1 Cosmetic formulations comprising porous silicon |